When engaging on the topic of cyber with boards and C-suite executives, it’s imperative to tie our focus to critical business issues.

Brian DePersiis

EY Americas Cybersecurity Strategy Leader

Passionate about providing strategic advice in the context of EY clients’ business imperatives to address their most critical cyber risks. Dedicated husband, father of two daughters. Yogi and golfer.

As the EY Americas Cybersecurity Strategy Leader, Brian meets with boards and C-suite executives to discuss the importance of their cyber risk management investments and to weigh in on the development of their strategic priorities.

Brian has over 20 years of experience in the areas of cybersecurity risk management, third-party security risk management and data protection, and privacy consulting. He is focused on helping clients implement cyber resiliency programs with a broader focus on cyber risk management, including board education; regulatory; audit; and compliance initiatives. Brian also works closely with his clients to address evolving risk areas in their cyber programs based on where key business investments are being made — with a focus on using industry frameworks and leading practices as a model.

Brian’s industry experience spans the life sciences, health care, pharmaceutical and biotech sectors.

How Brian is building a better working world

I work closely with pharmaceutical and biotech clients to help protect their data from nefarious threat actors. It’s so important that we understand the business of the business for our clients who are working on groundbreaking science and developing new disease treatment options. Working this way makes it easy to see tangible beneficial outcomes resulting from our efforts as cybersecurity and risk management professionals.

My daughter, Addie, is a brain tumor cancer survivor. Our family has experienced the life-saving impact of first-time medical advancements and groundbreaking treatments. The treatment plan that was developed for her is the basis of a clinical trial that’s now underway for patients with a similar illness.

I wake up every day thinking about how we can help our clients use data like this to develop future treatment options and protect it in a way that enables others to thrive in life, just as Addie has.

Our latest thinking

    Contact Brian